医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Exploring the protection of participants'compensation under new regulations

摘要Medical progress is based on research.Life sciences and medical research contribute to the improvement of peo-ple's health,alleviation of suffering,and increases in well-being.Life sciences and medical research involving hu-man participants cannot be undertaken without the support and dedication of participants.The safety,health,and welfare of participants are primary considerations in clinical research,taking precedence over the benefits to sci-ence and society.The rights and interests of participants include the right to health,the right to informed consent,the right to compensation,the right to privacy protection,the right to voluntary participation,the right to withdraw at any time,the study/trial free right,and the right to timely treatment.Protecting the rights of participants is the responsibility of sponsors,contract research organizations,medical institutions,researchers,ethics review com-mittees,and other research parties.In life sciences and medical research involving humans,participants typically expend time and energy,and partic-ipating in clinical research involves a degree of inconvenience in participants'work and life.When participating in studies in which safety and effectiveness have not been fully and effectively verified,participants are often ex-posed to uncertain types and levels of risk.Participants in such studies bear known and unknown risks,and may suffer research-related damages.Guaranteeing,protecting,and implementing participants'right to compensation are essential responsibilities in life sciences and medical research involving human participants.The current paper examines the right of compensation for research participants.We undertook in-depth analysis of the concepts,categories(conventional compensation,research-related damages),principles(necessity,timeliness,appropriateness,fairness),and elements(method,amount,plan,consent,notification,reference)of compensation,as well as compensation under special circumstances(people who have not given informed consent,participants with impaired informed consent capacity,participants who withdraw from a study).Additionally,we examined processes for research-related damages(claims,opinions,negotiation,implementation).This paper proposes mea-sures for the compensation rights of participants,which cover five domains(sponsor/contract research organiza-tions,research institutions,research management departments,the principal researchers and their teams,and ethics review committees),to ensure the implementation of compensation and strengthen the protection of the compen-sation rights of participants.

更多
广告
作者 Aijuan Sheng [1] Xiaoqi Wang [1] Sha Meng [1] Meixia Wang [2] Liyan Sun [3] Cuiling Zhao [4] Guizhen Sun [1] Dongxiang Zheng [1] Fang Liu [5] 学术成果认领
作者单位 Ethical Review Committee,Beijing Youan Hospital,Capital Medical University,Beijing 100069,China [1] Office of National Drug Clinical Trials Institution,Beijing Jishuitan Hospital,Beijing 100035,China [2] Office of Drug Clinical Trials Institution,Yantaishan Hospital Yantai,264008,China [3] Ethics Committee,Beijing Friendship Hospital Pinggu Campus,Capital Medical University,Beijing 101200,China [4] Capital Medical University,Beijing 100069,China [5]
栏目名称
发布时间 2025-04-10(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览3
  • 下载0
感染控制(英文)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷